Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
01/2006
01/24/2006US6989250 Isolation of nucleotide sequences coding preferential protein; obtain nucleotide sequences, mutate, incubate with oligonucleotide primers, amplify and isolate single-stranded nucleotide sequences, generate preferential nucleic acids
01/24/2006US6989246 Sensor formulation for simultaneously monitoring at least two components of a gas composition
01/24/2006US6989245 Screening for modulator of enzyme activity; diagnosing cancer in mammals; obtain sample containing preferential enzymatic actvity, incuabte with test compound, monitor adjustment in enzyme activity
01/24/2006US6989244 Method for screening compounds inhibiting signal transduction through inflammatory cytokines
01/24/2006US6989243 Apparatus for use in the detection of preferential compounds in sample
01/24/2006US6989241 Assay for rapid detection of human activated protein C and highly specific monoclonal antibody therefor
01/24/2006US6989240 Method for detecting hemolysis
01/24/2006US6989235 Single molecule detection of bio-agents using the F1-ATPase biomolecular motor
01/24/2006US6989234 Method and apparatus for non-contact electrostatic actuation of droplets
01/24/2006US6989233 Method and device for analyzing nucleic acids immobilized on a support
01/24/2006US6989232 Methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins
01/24/2006US6989175 Immobilization; fluorination
01/24/2006US6989086 Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresis
01/24/2006CA2398477C Methods for determining risk of developing cervical cancer
01/19/2006WO2006007603A2 Compositions and methods for detection of hepatitis a virus nucleic acid
01/19/2006WO2006007567A2 Methods and compositions to detect nucleic acids in a biological sample
01/19/2006WO2006007534A2 System and method for processing results of a complex genetic test
01/19/2006WO2006007479A2 Method for enumerating mammalian cell micronuclei via differential staining
01/19/2006WO2006007472A2 Non-invasive glucose measurement
01/19/2006WO2006007452A1 Sensor-dispensing instrument and method of using the same
01/19/2006WO2006007450A2 Detection, evaluation and treatment for advanced prostate cancer
01/19/2006WO2006007377A2 Methods of screening for bridge-1-mediated disorders, including type ii diabetes
01/19/2006WO2006007254A2 Biomarkers for wound healing
01/19/2006WO2006007207A2 Methods and devices for nucleic acid sequence determination
01/19/2006WO2006007180A2 Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia
01/19/2006WO2006007134A2 Jm-27 asa a marker of benign prostatic hyperplasia
01/19/2006WO2006006961A1 Enzymatic detection techniques
01/19/2006WO2006006960A1 One-step enzymatic and amine detection technique
01/19/2006WO2006006948A2 METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY
01/19/2006WO2006006853A2 Differences in intestinal gene expression profiles
01/19/2006WO2006006722A1 Method of controlling cell functions
01/19/2006WO2006006078A1 Cancer treatment resistance and agents modulating such resistance
01/19/2006WO2006006072A1 Methods for predicting therapeutic response to agents acting on the growth hormone receptor
01/19/2006WO2006005770A2 Method for the detection of fusarium graminearum
01/19/2006WO2006005718A2 Novel sequence for improving expression of nucleic acid
01/19/2006WO2006005636A1 Microfluidic device for performing a plurality of reactions and uses thereof
01/19/2006WO2006005472A1 Diagnostics and therapeutics for diseases associated with vanilloid receptor 1 (vr1)
01/19/2006WO2006005471A1 Diagnostics and therapeutics for diseases associated with vanilloid receptor 2 (vr2(vrl-1))
01/19/2006WO2006005462A2 Diagnostics and therapeutics for diseases associated with tyrosine kinase wee 1 (wee1)
01/19/2006WO2006005371A1 Microfluidic device for performing a plurality of reactions and uses thereof
01/19/2006WO2005111233A3 Methods and kits to detect hereditary angioedema type iii
01/19/2006WO2005106026B1 Use of genes as molecular markers in diagnosis of schizophrenia and diagnostic kit for the same
01/19/2006WO2005094324A3 Mixed cell diagnostic systems
01/19/2006WO2005093102A3 Array print buffers
01/19/2006WO2005087948A3 Cancer treatment and assays for determining resistance to platinum-based chemotherapeutic agent
01/19/2006WO2005085412A3 Method and device for the measurement and characterisation of a biomass, application thereof in relation to on-line biomass data measuring in a fermentation process and associated control method
01/19/2006WO2005076908A3 Anti-freeze protein enhanced nucleic acid amplification
01/19/2006WO2005074609A3 Test strip composition and method to measure cholesterol from low density lipoproteins
01/19/2006WO2005071080A3 Modulation of glucocorticoid receptor expression
01/19/2006WO2005066372A3 Quantitative amplification and detection of small numbers of target polynucleotides
01/19/2006WO2005046452A3 A polypeptide complex that regulates cell cycle and anergy
01/19/2006WO2005038005A3 Shc proteins as therapeutic targets in proliferative diseases
01/19/2006WO2004053074A3 Outcome prediction and risk classification in childhood leukemia
01/19/2006US20060015972 Plant transcriptional regulators of drought stress
01/19/2006US20060015965 Novel isoamylases and associated methods and products
01/19/2006US20060015964 Soybean genes for resistance to aphis glycines
01/19/2006US20060015955 Alpha(1,3)Galactosyltransferase enzyme that assembles the Galalpha(1,3)Gal xenoantigen
01/19/2006US20060015954 GPR54 knock-out mammals and screening methods using them
01/19/2006US20060014931 Novel promoter
01/19/2006US20060014930 Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses
01/19/2006US20060014801 Prevention and treatment of cognitive impairment using (R)-(-)-5-methyl-1-nicotynoyl-2-pyrazoline (MNP) and analogs
01/19/2006US20060014746 Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands
01/19/2006US20060014686 Screening for agents that modulate the activity or expression of FOXM1; determining whether a subject has lung, colon, or breast cancer
01/19/2006US20060014672 Tumor specific oligosaccharide epitopes and use thereof
01/19/2006US20060014315 Stable, water-soluble quantum dot, method of preparation and conjugates thereof
01/19/2006US20060014298 Method and kitset for sampling and storage of biological samplies
01/19/2006US20060014282 Cell and tissue engineering utilizing LIF
01/19/2006US20060014276 Chimeric adenoviruses
01/19/2006US20060014269 Automatic system for hybridizing nucleic acids, proteins, tissues on slide; depressions trap bubbles; pipetter
01/19/2006US20060014243 Human G-protein chemokine receptor HSATU68
01/19/2006US20060014242 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
01/19/2006US20060014238 Method and system for automated detection of immunohistochemical (IHC) patterns
01/19/2006US20060014237 Sensor comprising multi-wavelength LEDs
01/19/2006US20060014236 System for detection of biological agents
01/19/2006US20060014235 in vitro method for quantifying exposure to psychological stress which relies on measuring the retained ability of neutrophils, preferably neutrophils in a whole blood sample, to exhibit challenge-induced superoxide anion production; drug screening
01/19/2006US20060014234 Protected phosphorylated proteins or peptides are captured by reaction with a diazo moiety linked to a separation medium, isolated from the non-phosphorylated components of the mixture, released from the separation medium, and subsequently characterized by physicochemical means
01/19/2006US20060014233 Methods for measuring ADAMTS13 activity and protein on platelets and in plasma
01/19/2006US20060014232 Immobilization method
01/19/2006US20060014231 Methods and compositions to promote bone homeostasis
01/19/2006US20060014230 Beta-lactamase detecting reagent composition, detection kit and detection method
01/19/2006US20060014229 reacting sample with cholesterol esterase and cholesterol oxidase or oxidized coenzyme and cholesterol dehydrogenase in aqueous medium comprising nonionic surfactant, dextran sulfate and albumin, and measuring formed hydrogen peroxide
01/19/2006US20060014219 Method for measuring ion channel activity
01/19/2006US20060014218 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 1 (npff1)
01/19/2006US20060014205 Novel polymerase compositions and uses thereof
01/19/2006US20060014204 Methods of inducing formation of functional and organized lymphatic vessels
01/19/2006US20060014203 carbon nanotubes as electrodes; for biopolymers such as DNA and RNA
01/19/2006US20060014202 production method of electrical connection structure and electric wiring; carbon nanotube as the electrode and contacting the electrode with the biopolymer (DNA, RNA, or a protein) then applying an electric current between the electrode and biopolymer
01/19/2006US20060014201 Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof
01/19/2006US20060014200 Apparatus for analysis of a nucleic acid amplification reaction
01/19/2006US20060014199 Molecular detection of chromosome aberrations
01/19/2006US20060014198 Method for apparatus for detecting luminescence light from a porous support structure
01/19/2006US20060014197 In vivo screening methods for identifying inhibitors of RNA polymerases
01/19/2006US20060014196 Nanogripper device and method for detecting that a sample is gripped by nanogripper device
01/19/2006US20060014195 Investigation of DNA samples
01/19/2006US20060014194 Melanocortin receptor-specific hexapeptides
01/19/2006US20060014193 Nucleoside phosphoramidates and nucleoside phosphoramidases
01/19/2006US20060014192 Methods for genotype screening using magnetic particles
01/19/2006US20060014191 Analog probe complexes
01/19/2006US20060014190 Methods for analyzing short tandem repeats and single nucleotide polymorphisms
01/19/2006US20060014189 Controls for determining reaction performance in polynucleotide sequence detection assays